THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
First IMI Ebola projects get underway
IMI is launching the first eight projects of its Ebola+ programme, covering vaccine development, manufacture and uptake as well as diagnostics.
- Read the press release
- 27/02/2015 : The Feb newsletter is online- it's been a busy month for our projects on #autism #schizophrenia #antibiotics & more http://t.co/EQm0MrSpB3
- 27/02/2015 : RT @Open_PHACTS: Presentations and photos from last week's Open PHACTS workshop at @UniversidadeUSC are online! http://t.co/RIeDBO7mw5 http…
- 26/02/2015 : RT @PROTECT_BR: The materials presented at the Benefit-Risk Workshop of the PROTECT Symposium at the EMA are now available on http://t.co/h…